Note: Ingredients listed on restricted chemical lists
EC/CAS
220-449-8/2768-02-7
Name of the chemical
Trimethoxyvinylsilane
Concentration
0.1 - 1
EC/CAS
245-152-0/22673-19-4
Name of the chemical
Dibutylbis(pentan-2,4-dionato-O,O’)zinn (2020/217)
Concentration
0.1 - 1
General Information
Version
1.1
Revision date
2022-02-24
Product name
AS-4001 / AS-4001S MS Construction Sealant
1.2.1 Relevant identified uses
Industrial use,Professional use
Manufacturer Name
Alseal Marketing Sdn. Bhd
Icons in SDS
Company Information
company name
Alseal Marketing Sdn. Bhd
e-mail address of the competent person responsible for the Safety Data Sheet
info@alsealmarketing.com
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice.
2.2 Label elements
Labelling
Supplemental label elements
EUH208 - Contains N-(3-(TRIMETHOXYSILYL)PROPYL)ETHYLENEDIAMINE, TRIMETHOXYVINYLSILANE. May produce an allergic reaction. EUH210 - Safety data sheet available on request.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component DIBUTYLBIS(PENTANE-2,4-DIONATO-O,O')TIN This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII (22673-19-4) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component DIBUTYLBIS(PENTANE-2,4-DIONATO- The substance is not included in the list established in accordance with Article 59(1) of O,O')TIN(22673-19-4) REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
